Stay updated on Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.

Latest updates to the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has updated its date references, removing past dates from 2024 and adding new dates in May 2025.SummaryDifference0.8%
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check45 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed study information regarding a Phase III trial for Squamous Cell Carcinoma of the Head and Neck, while adding a new study reference and a revision note.SummaryDifference44%
- Check52 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.